Clinical Trial Update: Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update reporting results on the pharmacokinetics of triglyceride-rich lipoproteins ApoB48 and ApoB100 in patients with Type 2 Diabetes Me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)

Snippet

Sponsor: Laval University | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-09-10